DaVita Kidney Care Announces its First Chief Medical Officer for International Operations

BANGALORE, February 25, 2015 /PRNewswire/ --

Company Appoints Clinical Leader of Global Physicians

DaVita HealthCare Partners, a leading international provider of kidney care services headquartered in the U.S., today announced that Mahesh Krishnan, will serve as the company's international chief medical officer (CMO) and group vice president of research and development to implement global clinical initiatives.

"I'm excited to have the opportunity to work with our talented group of global nephrologists and teammates to help positively impact worldwide patient outcomes," Krishnan said. "Developing an infrastructure to share best practices, improve clinical outcomes and cross-pollinate clinical research is our top priority."

Krishnan previously served as DaVita Kidney Care's vice president of clinical research, innovation and public policy. Prior to joining DaVita Kidney Care in 2009, Krishnan worked in various nephrology leadership positions with Amgen, heading up global health economics and outcomes research for nephrology. He also was responsible for overseeing the Dialysis Outcomes Practice Pattern Study, an international registry of hemodialysis patients.

"Dr. Krishnan has vast experience and a proven track record of success domestically and internationally," said Dennis Kogod, CEO of DaVita Kidney Care's international business and president of HealthCare Partners. "His expertise will enhance our commitment to clinical differentiation and help bring quality care to our patients around the world."

DaVita Kidney Care is committed to clinical excellence and has improved patient outcomes in the U.S. for 15 consecutive years and counting, the benefits of which include fewer hospitalizations and better health-related quality of life.

DaVita Kidney Care has established successful operations in 10 countries outside of the U.S. In 2014, DaVita Kidney Care signed a tender from the Kingdom of Saudi Arabia's Ministry of Health to treat half of the nearly 10,000 patients currently under the ministry's care.

DaVita Kidney Care in India also received recognition from India Healthcare Excellence Awards as the Dialysis Service Provider Company of the Year in the specialty chain category by Frost and Sullivan.

Finally, the Jalan Tun Razak dialysis center in Kuala Lumpur, Malaysia, became the first stand-alone dialysis center in the country to receive a four-year accreditation in chronic dialysis treatment from the Malaysian Society for Quality in Health.

For more information on DaVita Kidney Care's international operations, visit DaVita.com/About/International.

About DaVita Kidney Care in India 

DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a global company that, through its operating divisions, provides a variety of health care services to patient populations in India and throughout Asia, Europe, the Middle East, and Latin America. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end-stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of September 30, 2014, DaVita Kidney Care operated or provided administrative services at 2,239 outpatient dialysis centers worldwide serving approximately 176,500 patients. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. For more information, please visit DaVita.In.

DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc.

Media Contact

Navami Rika Banerji

[email protected]

+91-9742844556

Manager - Corporate Communications

DaVita Care (India) Pvt. Ltd.